Ignite Creation Date:
2024-05-06 @ 11:03 AM
Last Modification Date:
2024-10-26 @ 12:39 PM
Study NCT ID:
NCT03423992
Status:
UNKNOWN
Last Update Posted:
2021-06-15
First Post:
2018-01-22
Brief Title:
Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas
Sponsor:
Xuanwu Hospital Beijing
Organization:
Xuanwu Hospital Beijing
Organization Data
Organization:
Xuanwu Hospital Beijing
Class:
OTHER
Study ID:
Xuanwu hospital
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Xuanwu Hospital Beijing
Lead Sponsor Class:
OTHER
Responsible Party:
Qingtang Lin
Responsible Party Title:
Associate Professor Department of Neurosurgery
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Xuanwu Hospital Beijing
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Beijing HuiNengAn Biotech Company | UNKNOWN |
| Beijing Mario Biotech Company | UNKNOWN |
| Hebei Senlang BIotech Company | UNKNOWN |